It is a setback for one of the most talented Indian boxers eyeing the medal glory at the 2020 Tokyo games.
Olympian and reigning national Champion(91kg), Sumit Sangwan was on Thursday banned for one year by the Anti-Doping Agency(NADA) after traces of banned specified substance, Acetazolamide was found in his urine sample during an in-competition testing on October 10.
Sangwan’s ban period started on December 26, the date order by the NADA’s Anti-Dopin desciplinary panel(ADDP).
The ban means Sangwan will not be able to participate in the men’s selection trials for the Olympic qualifiers, scheduled to be held in Bellary on December 29-30.
The selected boxers will represent India in the first Tokyo qualifiers in Wuhan,China from February 3-14.
Sangwan will also have to forfeit his bronze medal won at the Olympic test event in Tokyo in October, because the boxer hasn’t opted for voluntary provisional suspension provided in the case of specified substance, and continued participating in tournaments.
While Sangwan’s team could convince the NADA’s three members panel that Sangwan took the medicine which contain the said substance “unintentionally” for the treatment of his right eyes injury, the panel was of the view that it is the personal duty of each athlete to ensure that no prohibited substance enters their body.
Sangwan, has on his part, contended that he had consulted a sport authority of Indian doctors(SAI) who prescribed to him certain anti biotic and eye drops for his eye infection.
Taking a considerate view, the ADDP charged Sangwan with the Anti-Doping rules violation, but let him off with a suspension period of one year which will end on December 25,2020.